Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: A signaling mechanism for both nitric oxide- induced and ischemia-induced preconditioning

Circulation Research

Volumn 84, Issue 5, 1999, Pages 587-604

  Ping, Peipei ^a,b,c   Takano, Hitoshi ^a   Zhang, Jun ^a   Tang, Xian Liang ^a   Qiu, Yumin ^a   Li, Richard C X ^a   Banerjee, Supratim ^a   Dawn, Buddhadeb ^a   Balafonova, Zarema ^a,b   Bolli, Roberto ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Diethylenetriamine; N( ) nitro L arginine; Nitric oxide; Protein kinase C isoform; S nitroso N acetylpenicillamine; Translocation

Indexed keywords

CHELERYTHRINE; DIETHYLENETRIAMINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN KINASE C;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE TRANSLOCATION; HEART INFARCTION; HEART PROTECTION; HEART RATE; IMMUNOBLOTTING; ISCHEMIA; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RABBIT; REPERFUSION; SIGNAL TRANSDUCTION; STUNNED HEART MUSCLE; SYSTOLIC BLOOD PRESSURE;

EID: 0033583131     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.5.587     Document Type: Article

References (69)

1. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, Tada M. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res. 1993;72:1293-1299.
2. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 1993;88: 1264-1272.
3. Sun J-Z, Tang X-L, Knowlton AA, Park SW, Qiu Y, Bolli R. Late preconditioning against myocardial stunning: an endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs. J Clin Invest. 1995;95:388-403.
4. Sun J-Z, Tang X-L, Park SW, Qiu Y, Turrens JF, Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest. 1996;97:562-576.
5. Tang X-L. Qiu Y, Park SW, Sun J-Z, Kalya AA, Bolli R. Time course of late preconditioning against myocardial stunning in conscious pigs. Circ Res. 1996;79:424-434.
6. Baxter GF, Goma FM, Yellon DM. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Br J Pharmacol. 1995;115:222-224.
7. Maldonado C, Qiu Y, Tang X-L, Cohen MV, Manchikalapudi S, Auchampach J, Bolli R. Role of adenosine receptors in late preconditioning against myocardial stunning in conscious rabbits. Am J Physiol. 1997;273:1324-1332.
8. Bolli R, Bhatti ZA, Tang X-L, Qiu Y, Zhang Q, Guo Y, Jadoon AK. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 1997;81:42-52.
9. Bolli R, Manchikalapudi S, Tang X-L, Takano H, Qiu Y, Zhang Y, Guo Y, Jadoon AK. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: evidence that nitric oxide acts both as a trigger and as mediator of the late phase of preconditioning. Circ Res. 1997;81:1094-1107.
10. Qiu Y, Rizvi A, Tang X-L, Manchikalapudi S, Takano H, Jadoon AK, Wu W-J, Bolli R. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol. 1997;273: 2931-2936.
11. Takano H, Manchikalapudi S, Tang X-L, Qiu Y, Rizvi A, Jadoon AK, Zhang Q, Bolli R. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation. 1998;98:441-449.
12. Marber MS, Yellon DM. Myocardial adaptation, stress proteins, and the second window of protection. Ann NY Acad Sci. 1996;793:123-141.
13. Bolli R. The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an overview. Basic Res Cardiol. 1996;91:57-63.
14. Takano H, Tang X-L, Qiu Y, Guo Y, French BA, Bolli R. Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ Res. 1998;83:73-84.
15. Downey JM, Cohen MY, Ytrehus K, Liu Y. Cellular mechanisms in ischemic preconditioning: the role of adenosine and protein kinase C. Ann NY Acad Sci. 1994;723:82-98.
16. Cohen MV, Downey JM. Preconditioning during ischemia: basic mechanism and potential clinical applications. Cardiol Res. 1995;3: 137-149.
17. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol. 1994;266:1145-1152.
18. Liu Y, Ytrehus K, Downey JM. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol. 1994;26:661-668.
19. Liu Y, Cohen MV, Downey JM. Chelerythrine, a highly selective protein kinase C inhibitor, blocks the antiinfarct effect of ischemic preconditioning in rabbit hearts. Cardiovasc Drugs Ther. 1994;8:881-882.
20. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res. 1994;75:586-590.
21. Li Y, Kloner RA. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am J Physiol. 1995;268:426-431.
22. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res. 1995;76:73-81.
23. Armstrong SC, Downey JM, Ganote CE. Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc Res. 1994;28:72-77.
24. Speechly-Dick ME, Grover GJ, Yellon DM. Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K* channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res. 1995;77:1030-1035.
25. Armstrong SC, Ganote CE. Preconditioning of isolated rabbit cardiomyocytes: effects of glycolytic blockade, phorbol esters, and ischaemia. Cardiovasc Res. 1994;28:1700-1706.
26. Strasser RH, Braun M, Schon SH, Kempkes A, Ihi-Vahl R, Marquetant R. Two distinct mechanisms induce a subtype-selective activation of protein kinase C in acute myocardial ischemia. J Am Coll Cardiol. 1996; 27:292A. Abstract.
27. Miyamae M, Rodriguez MM, Camacho SA, Diamond I, Mochly-Rosen D, Figueredo VM. Activation of epsilon protein kinase C correlates with a cardioprotective effect of regular ethanol consumption. Proc Natl Acad Sci USA. 1998;95:8262-8267.
28. Gray MO, Karliner JS, Mochly-Rosen D. A selective ∈-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem. 1997;272:30945-30951.
29. Vahlhaus C, Schulz R, Post H, Rose J, Heusch G. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase. J Mol Cell Cardiol. 1998;30:197-209.
30. Armstrong SC, Hoover DB, Delacey MH, Canote CE. Translocation of PKC, protein phosphatase inhibition and preconditioning of rabbit cardiomyocytes. J Mol Cell Cardiol. 1995;28:1479-1492.
31. 1-receptor-independent activation of protein kinase C in acute myocardial ischemia: mechanisms for sensitization of the adenylyl cyclase system. Circ Res. 1992;70:1304-1312.
32. Ping P, Zhang J, Qiu Y, Tang X-L, Manchikalapudi S, Cao X, Bolli R. Ischemic preconditioning induces selective translocation of protein kinase C isoforms ∈ and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res. 1997;81: 404-414.
33. Qiu Y, Ping P, Tang X-L. Manchikalapudi S, Rizvi A, Zhang J, Takano H, Wu W-J, Teschner S, Bolli R. Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that ∈ is the isoform involved. J Clin Invest. 1998;101:2182-2198.
34. Triana JF, Li XY, Jamaluddin U, Thornby JI, Bolli R. Postischemic myocardial "stunning": identification of major differences between the open-chest and the conscious dog and evaluation of the oxygen radical hypothesis in the conscious dog. Circ Res. 1991;69:731-747.
35. Li XY, McCay PB, Zughaib M, Jeroudi MO, Triana JF, Bolli R. Demonstration of free radical generation in the "stunned" myocardium in the conscious dog and identification of major differences between conscious and open-chest dogs. J Clin Invest. 1993;92:1025-1041.
36. Haessler R, Kuzume K, Chien GL, Wolff RA, Davis RF, Van Winkle DM. Anaesthetics alter the magnitude of infarct limitation by ischemic preconditioning. Cardiovasc Res. 1994;28:1574-1580.
37. Bolli R. Common methodological problems and artifacts associated with studies of myocardial stunning in vivo. Basic Res Cardiol. 1995;90: 257-262.
38. Dunker DJ, Klassen CL, Ishibashi Y, Herrlinger SH, Pavek TJ, Bache RJ. Effect of temperature on myocardial infarction in swine. Am J Phvsiol. 1996;270:H1189-H1199.
39. Schwartz LM, Verbinski SG, Vander Heide RS, Reimer KA. Epicardial temperature is a major predictor of myocardial infarct size in dogs. J Mol Cell Cardiol. 1997;29:1577-1583.
40. Schwartz LM, Jennings RB, Reimer KA. Premedication with the opioid analgesic butorphanol raises the threshold for ischemic preconditioning in dogs. Basic Res Cardiol. 1997;92:106-114.
41. 6-(3-iodobenzyl) adenosine-5′-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res. 1997;80:800-809.
42. Akimoto K, Mizuno K, Osada S, Hirai S, Tanuma S, Suzuki S, Ohno S. A new member of the third class in the protein kinase C family, PKC lambda, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells. J Biol Chem. 1994;269:12677-12683.
43. Selbie LA, Schmitz-Peiffer C, Sheng Y, Biden TJ. Molecular cloning and characterization of PKC iota, an atypical isoform of PKC derived from insulin-secreting cells. J Biol Chem. 1993;268:24296-24302.
44. Rybin VO, Buttrick PM. Steinberg SF. PKC-lambda is the atypical protein kinase C isoform expressed by immature ventricle. Am J Physiol. 1997;272:1636-1642.
45. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
46. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A. 1996;93:6770-6774.
47. Huk I, Nanobashvili J, Neumayer C, Punz A, Mueller M, Afkhampour K, Mittlboeck M, Losert U, Polterauer P, Roth E, Patton S, Malinski T. L-Arginine treatment alters the kinetics of nitric oxide and superoxide release and induces ischemia/reperfusion injury in skeletal muscle. Circulation. 1997;96:667-675.
48. Wever RMF, Luscher TF, Consentino F, Rabelink TJ. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation. 1998; 97:108-112.
49. Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, Bove AA, Isaac L, Hrabie JA, Keefer LK. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide: vasorelaxant effects. J Med Chem. 1991;34:3242-3247.
50. Mooradian DL, Hutsell TC, Keefer LK. Nitric Oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol. 1995;25:674-678.
51. Hampl V, Tristani-Firouzi M, Hutsell TC, Archer SL. Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension. Cardiovasc Res. 1996;31:55-62.
52. Shaffer JE, Han B-J, Chern WH, Lee FW. Lack of tolerance to a 24-hour infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits. J Pharmacol Exp Ther. 1992;67:286-293.
53. Serone AP, Angus JA, Wright CE. Baroreflex resetting but no vascular tolerance in response to transdermal glyceryl trinitrate in conscious rabbits. Br J Pharmacol. 1996;118:93-104.
54. Przyklenk K, Sussman MD, Simkhovich BZ, Kloner RA. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation. 1995;92:1546-1557.
55. Simkhovich BZ, Przyklenk K, Hale SL, Patterson M, Kloner RA. Direct evidence that ischemic preconditioning does not cause PKC translocation in rabbit heart. Cardiovasc Res. 1996;32:1064-1070.
56. Herbert JM, Augereau JM, Gleye J, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophvs Res Commun. 1990;172:993-999.
57. Ping P, Zhang J, Li RCX, Tang XL, Qiu Y, Banerjee S, Zheng YT, Bolli R. Ischemic preconditioning (PC) induces selective activation of Src and Lck tyrosine kinases in conscious rabbits via a PKC-dependent pathway. Circulation. 1998;98(suppl I):I-71. Abstract.
58. Liu Y, Sato T, O'Rourke B, Marbán E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation. 1998;97:2463-2469.
59. Kelly RA, Balligand J-L, Smith TW. Nitric oxide and cardiac function. Circ Res. 1996;79:363-380.
60. Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol. 1995;57:737-769.
61. 1-Adrenergic agonist precondition rabbit ischemic myocardium independent of adenosine by direct activation of PKC. Circ Res. 1994;75:576-585.
62. Goto M. Liu YL, Yang XM, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 1995;77:611-621.
63. Baxter GF, Marber MS, Patel VC, Yellon DM. Adenosine receptor involvement in a delayed phase of myocardial protection 24 h after ischemic preconditioning. Circulation. 1994;90:2993-3000.
64. Tritto I, D'Andrea D, Eramo N, Scognamiglio A, DeSimone C, Violante A, Esposito A, Chiariello M, Ambrosio G. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res. 1997;80:743-748.
65. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol. 1997;29:207-216.
66. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990;87:1620-1624.
67. 2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Natl Acad Sci USA. 1989;86:6758-6762.
68. Natarajan V, Taher MM, Roehm B, Parinandi NL, Schmid HH, Kiss Z, Garcia JG. Activation of endothelial cell phospholipase D by hydrogen peroxide and fatty acid hydroperoxide. J Biol Chem. 1993;268:930-937.
69. Cohen MV, Liu Y, Liu GS, Wang P, Weinbrenner C, Cordis GA, Das DK, Downey JM. Phospholipase D plays a role in ischemic preconditioning in rabbit heart. Circulation. 1996;94:1713-1718.